bimatoprost ocular insert (13 mg)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for bimatoprost ocular insert (13 mg), covering 2019-02-26 to 2019-02-26. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert [Phase 2]